Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients
Bisagni, Alessandra, Pagano, Maria, Maramotti, Sally, Zanelli, Francesca, Bonacini, Martina, Tagliavini, Elena, Braglia, Luca, Paci, Massimiliano, Mozzarelli, Andrea, Croci, Stefania, Lee, Jung WeonVolume:
13
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0196350
Date:
April, 2018
File:
PDF, 3.85 MB
english, 2018